Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ligand Pharmaceuticals Inc (LGND)  
$72.32 0.90 (1.26%) as of 4:30 Thu 5/2


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 18,090,000
Market Cap: 1.31(B)
Last Volume: 562,071 Avg Vol: 560,510
52 Week Range: $49.57 - $89.2
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1017
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 4,000 6,500
Total Buy Value $0 $0 $237,529 $444,439
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 1 2
Total Shares Sold 2,033 2,033 19,293 47,289
Total Sell Value $153,034 $153,034 $1,480,968 $3,568,168
Total People Sold 2 2 3 5
Total Sell Transactions 2 2 5 12
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 966
  Page 10 of 39  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lamattina John L Director   –       •      –    2019-06-06 4 A $0.00 $0 D/D 835 22,284     -
   Higgins John L Chief Executive Officer   •       •      –    2019-05-31 4 B $108.20 $108,202 D/D 1,000 144,899 2.81     -
   Aryeh Jason Director   –       •      –    2019-05-31 4 AB $108.51 $54,255 D/D 500 60,618     -
   Aryeh Jason Director   –       •      –    2019-05-30 4 AB $110.01 $27,503 D/D 250 60,118     -
   Aryeh Jason Director   –       •      –    2019-05-29 4 AB $111.01 $27,753 D/D 250 59,868     -
   Aryeh Jason Director   –       •      –    2019-05-20 4 AB $112.01 $28,003 D/D 250 59,618     -
   Aryeh Jason Director   –       •      –    2019-05-14 4 AB $112.51 $28,128 D/D 250 59,368     -
   Kozarich John W Director   –       •      –    2019-05-14 4 S $112.92 $282,300 D/D (2,500) 25,542     -
   Kozarich John W Director   –       •      –    2019-05-14 4 OE $17.88 $44,700 D/D 2,500 28,042     -
   Higgins John L Chief Executive Officer   •       •      –    2019-05-14 4 B $113.50 $283,750 D/D 2,500 143,899 2.81     -
   Foehr Matthew W President and COO   •       –      –    2019-03-14 4 OE $9.97 $148,493 D/D 14,894 140,447     -
   Higgins John L Chief Executive Officer   •       •      –    2019-03-13 4 B $114.29 $285,725 D/D 2,500 141,399 2.81     -
   Aryeh Jason Director   –       •      –    2019-03-13 4 B $112.51 $22,727 I/I 202 51,594 2.1     -
   Korenberg Matthew E EVP,Finance & Strategy and CFO   •       –      –    2019-02-15 4 D $120.86 $140,923 D/D (1,166) 15,303     -
   Foehr Matthew W President and COO   •       –      –    2019-02-15 4 D $120.86 $341,550 D/D (2,826) 122,727     -
   Higgins John L Chief Executive Officer   •       •      –    2019-02-15 4 D $120.86 $594,269 D/D (4,917) 133,982     -
   Higgins John L Chief Executive Officer   •       •      –    2019-02-11 4 A $0.00 $0 D/D 12,809 138,899     -
   Korenberg Matthew E EVP,Finance & Strategy and CFO   •       –      –    2019-02-11 4 A $0.00 $0 D/D 6,404 16,469     -
   Berkman Charles S SVP, Gen. Counsel & Secretary   •       –      –    2019-02-11 4 A $0.00 $0 D/D 3,202 45,897     -
   Foehr Matthew W President and COO   •       –      –    2019-02-11 4 A $0.00 $0 D/D 7,472 125,553     -
   Korenberg Matthew E EVP,Finance & Strategy and CFO   •       –      –    2019-01-23 4 D $111.78 $148,109 D/D (1,325) 10,065     -
   Korenberg Matthew E EVP,Finance & Strategy and CFO   •       –      –    2019-01-23 4 A $0.00 $0 D/D 4,648 10,677     -
   Foehr Matthew W President and COO   •       –      –    2019-01-23 4 D $111.78 $287,051 D/D (2,568) 118,081     -
   Foehr Matthew W President and COO   •       –      –    2019-01-23 4 A $0.00 $0 D/D 7,262 119,365     -
   Berkman Charles S SVP, Gen. Counsel & Secretary   •       –      –    2019-01-23 4 A $0.00 $0 D/D 2,782 42,695     -
  966 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 39
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us